Two Phase III trials found that apixaban was more effective for stroke prevention than either aspirin or warfarin in patients with atrial fibrillation (AF), with a similar (versus aspirin ...
There is controversy regarding the appropriate strategy (anticoagulation vs aspirin ... rate of bleeding than the rates with warfarin. Based on the AVEROSS trial, apixaban was superior to aspirin ...
TUESDAY, Feb. 11, 2025 (HealthDay News) -- Rates of major bleeding and intracranial hemorrhage are similar for apixaban and dabigatran ... intracranial hemorrhage than aspirin (risk differences ...